NCT04068597 2025-12-18Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesCellCentric Ltd.Phase 1/2 Recruiting250 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT02352558 2023-11-14A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic MalignanciesSumitomo Pharma America, Inc.Phase 1 Completed15 enrolled
NCT00439556 2019-09-10Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell TransplantM.D. Anderson Cancer CenterPhase 2 Completed40 enrolled 11 charts
NCT00068315 2013-09-30Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 1 Completed18 enrolled